Hepatitis B Virus Infection and Hepatitis C Virus Treatment in a Large Cohort of Hepatitis C –Infected Patients in the United States

The rare emergence of hepatitis B virus (HBV) reactivation among hepatitis C virus (HCV)-infected patients receiving direct-acting antiviral (DAA) therapy raises questions about how many HCV-infected patients have active, past, or latent/occult HBV co-infection, and their DAA treatment experience1 –3 We sought to characterize these factors, including possible post-DAA reactivation, among HCV patients in the Chronic Hepatitis Cohort Study (CHeCS), a “dynamic” observational study conducted at 4 large integrated U.S.

Source: Gastroenterology - January 19, 2018 Category: Gastroenterology Authors: Anne C. Moorman, Jian Xing, Loralee B. Rupp, Stuart C. Gordon, Philip R. Spradling, Joseph A. Boscarino, Mark A. Schmidt, Yihe G. Daida, Eyasu H. Teshale, Scott D. Holmberg, Chronic Hepatitis Cohort Study Investigators Tags: Correspondence Source Type: research